ResMed Reports 10% Revenue Growth, Sees Wearables and GLP-1s Driving Future Demand

Summary: ResMed reported 10% revenue growth for the quarter ending Dec 31, 2024, reaching $1.3 billion, driven by strong demand for sleep devices, masks, and residential care software. CEO Mick Farrell highlighted “once-in-a-generation” opportunities presented by the rise of sleep-tracking wearables and GLP-1 therapies, which he believes will increase patient awareness and drive greater adoption…

Read More

Kadimastem Shareholders Greenlight Merger with NLS

Summary: Kadimastem shareholders have approved the company’s merger with NLS Pharmaceutics, moving the two firms closer to forming a combined Nasdaq-traded company. NLS plans to hold its own shareholder vote in the coming weeks to finalize the merger. Executives from both companies highlighted the potential value creation and opportunities for growth and innovation resulting from…

Read More

HME Launches Pediatric Line With CPAP Masks and Ventilation Solutions

Summary: Sunset Healthcare Solutions has launched Brighter Pediatrics, a new product line designed to enhance pediatric respiratory therapy for home care providers and families. The line includes pediatric CPAP/NIV masks, ventilator circuits, and closed ventilation suction systems, along with the Microflow Microdial Flowmeter, which allows for precise oxygen adjustments for infants. Sunset Healthcare emphasizes its…

Read More

UK’s NICE Recommends Four Non-Airflow-Based HSTs

By Sree Roy The United Kingdom’s National Institute for Health and Care Excellence (NICE) assesses and recommends new medical technologies that practitioners can prescribe with confidence and that it deems have taxpayer value. NICE recently released new guidance recommending four non-airflow-based home sleep tests (HSTs). Because ResMed’s NightOwl is awaiting CE approval, NICE notes that…

Read More

NLS Abstracts Showcase Narcolepsy and Diabetes-Related Sleep Research

Summary: NLS Pharmaceutics Ltd has submitted three research abstracts to the 2025 Annual Meeting of the American Society of Clinical Psychopharmacology (ASCP), with two focusing on sleep-related conditions. One abstract presents preclinical findings on dual orexin receptor agonists (AEX-41 and AEX-2) for narcolepsy, showing wake-promoting properties without the metabolic side effects of traditional stimulants. Another…

Read More

Sleep Issues in Parkinson’s: A Closer Look at Patient Data

Summary: A new study from Maynooth University, based on data from over 38,000 Parkinson’s disease patients gathered by the Michael J. Fox Foundation, highlights the widespread prevalence of sleep disturbances in this population. The research, published in the Journal of Sleep Research, found that sleep issues are significantly more common in Parkinson’s patients compared to…

Read More